Market Place
Sourcing Support
FDA Unveils 34 New and Revised Product-Specific Draft Guidances
17 May 2019 //
RAPS
Singapore HSA Approves Biktarvy for Treatment of HIV-1 Infection
13 Feb 2019 //
PR NEWSWIRE
GSK looks to oncology for growth as Advair generic hits
06 Feb 2019 //
FIERCE PHARMA
Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV
22 Jan 2019 //
BIOSPACE
European Commission Grants Marketing Authorization for Gilead’s Biktarvy®
23 Jun 2018 //
PRESS RELEASE
GSK vs Gilead: Heavyweight HIV fight will come down to big showdown in Amsterdam
21 Jun 2018 //
ENDPTS
Three medicines step closer to EU approval
01 May 2018 //
PHARMA TIMES
Gilead strikes back at GSK with +ve HIV head-to-head trial data for blockbuster
07 Mar 2018 //
FIERCE PHARMA
US green light for Gilead’s HIV combo
08 Feb 2018 //
PHRMA TIMES
Sanofi`s diabetes sales hit hard by PBM formulary moves
07 Feb 2018 //
FIERCE PHARMA
Gilead gets a blockbuster boost from an FDA OK of HIV triplet Biktarvy
07 Feb 2018 //
ENDPTS
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
14 Dec 2017 //
ENDPTS
Gilead Announces New License Agreement, Medicines Patent Pool for Bictegravir
05 Oct 2017 //
PRESS RELEASE
The Medicines Patent Pool, Gilead sign licence for bictegravir
04 Oct 2017 //
PHARMABIZ
Gilead`s HIV Triple Combo Gets Sped-up FDA Review, Decision Date Locked Down
12 Aug 2017 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.